Novavax Inc. buy BTIG Research
Start price
20.01.26
/
50%
€7.35
Target price
20.01.27
€16.32
Performance (%)
21.81%
Price
13.03.26
€8.95
Summary
This prediction is currently active. The prediction currently has a performance of 21.81%. This prediction currently runs until 20.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 4.274% | 4.274% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat